Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage...

cafead

Administrator
Staff member
  • cafead   Jun 16, 2023 at 09:52: AM
via 78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapy

article source